Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American Anti-corruption Law Envelops The Globe, Hits Graft Even In China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - The U.S. is stepping up enforcement of its Foreign Corrupt Practices Act to combat bribery of government officials across great swaths of the globe, and even the health care sector as far away as Asia has not been immune in this anti-graft campaign

You may also be interested in...



China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm

BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities

China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm

BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities

China Sky One Blames U.S. Media Reports For Driving Down NASDAQ Share Price

BEIJING - Just months after threatening to sue an American shareholder for posting negative reports about China Sky One Medical on a U.S. Web site, the leadership of NASDAQ-traded Sky One has issued a new public declaration that unfavorable media reports about the firm that have been driving down its share price are unfounded and reckless

Related Content

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel